Polynucleotide encoding virus-derived protein
WO2025063261A1 Publication Date: 2025-03-27SHIONOGI & CO LTD
47 Cites 0 Cited by
Patent Information
- Application Number
- PCT/JP2024/033582
- Authority / Receiving Office
- WO · WO
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2023-09-22
- Filing Date
- 2024-09-20
- Publication Date
- 2025-03-27
Abstract
The purpose of the present invention is to provide a novel polynucleotide that efficiently expresses the HIV Tat protein or an antigenic fragment thereof and has an excellent ability to induce an anti-Tat antibody, and to provide a pharmaceutical composition containing the polynucleotide. Disclosed is a novel polynucleotide encoding a polypeptide comprising: (a) the HIV Tat protein or an antigenic fragment thereof; and (b) a signal peptide. The pharmaceutical composition containing the polynucleotide can be used for the treatment and / or prevention of HIV-related diseases.
Need to check novelty before this filing date? Find Prior Art